Detection of immunoglobulin response to COVID-19 vaccination using a novel rapid fingerstick assay.
Clin Immunol
; 235: 108791, 2022 02.
Article
in En
| MEDLINE
| ID: mdl-34214649
ABSTRACT
Coronavirus Disease 2019 (COVID-19) emerged as a global pandemic resulting in significant mortality and morbidity. COVID-19 vaccines have been shown to be highly effective in preventing COVID-19 infections and significantly reducing disease severity and mortality. We report on a novel COVID-19 antibody assay using a unique platform to rapidly detect SARS-CoV-2 antibodies with a drop of fingerstick blood in a subject following COVID-19 vaccination. We show early detection of SARS-CoV-2 antibodies post vaccination and persistence of detectable antibodies for at least 6 months. Rapid point of care COVID-19 antibody tests might have a role in assessing the appearance and durability of immune response following COVID-19 vaccination.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Immunoglobulins
/
Blood Specimen Collection
/
SARS-CoV-2
/
COVID-19
/
BNT162 Vaccine
/
Antibodies, Viral
Type of study:
Diagnostic_studies
/
Screening_studies
Limits:
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Clin Immunol
Journal subject:
ALERGIA E IMUNOLOGIA
Year:
2022
Document type:
Article